Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era.
Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era. Leuk Lymphoma. 2020 02; 61(2):298-308.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Dacarbazine
Disease-Free Survival
Doxorubicin
Hodgkin Disease
Humans
Retrospective Studies
Treatment Outcome
Vinblastine
authors with profiles
Mei-Yin Polley